首页 > 产品中心 > 有机化学

4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯苄酯

PF8380

产品编号.: A035539 CAS号: 1144035-53-9
分子式: C22H21Cl2N3O5 分子量: 478.3252
纯度: 98% MDL NO.:

中文名称：4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯苄酯
CAS号：1144035-53-9
中文别名：4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯苄酯;铁测试盒
英文名称：PF8380
英文别名：3,5-Dichlorobenzyl 4-(3-oxo-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)propyl)piperazine-1-carboxylate;PF-8380;3,5-Dichlorobenzyl 4-(3-oxo-3-(2-oxo-2,3-dihydrobenzo-[d]oxazol-6-yl)propyl)piperazine-1-carboxylate;PF 8380;PF-8380, ATX Inhibitor;3,5-dichlorobenzyl 4-[3-oxo-3-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propyl]piperazine-1-carboxylate;AK120450;CS-0591;HY-13344;SureCN3054811;X5984;4-[3-(2,3-Dihydro-2-oxo-6-benzoxazolyl)-3-oxopropyl]-1-piperazinecarboxylic acid (3,5-dichlorophenyl)methyl ester;4-[3-Oxo-3-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propyl]piperazine-1-carboxylic acid 3,5-dichlorobenzyl ester;PF8380;T582DIM5A4;(3,5-Dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate;MLS00601;Atx Inhi;C22H21Cl2N3O5;C22H21Cl2N3O5;C22H21Cl2N3O5;CHEMBL3186509;CHEMBL3186509;CHEMBL3186509;DTXSID50649524;DTXSID50649524;DTXSID50649524;compound 4 (PMID: 23300119);compound 4 (PMID: 23300119);compound 4 (PMID: 23300119);2(3H)-Benzoxazolone, 6-(1-oxo-3-(1-piperazinyl)propyl)-;2(3H)-Benzoxazolone, 6-(1-oxo-3-(1-piperazinyl)propyl)-;2(3H)-Benzoxazolone, 6-(1-oxo-3-(1-piperazinyl)propyl)-;HMS3740G07;HMS3740G07;HMS3740G07;1-Piperazinecarboxylic acid, 4-[3-(2,3-dihydro-2-oxo-6-benzoxazolyl)-3-oxopropyl]-, (3,5-dichlorophenyl)methyl ester;1-Piperazinecarboxylic acid, 4-[3-(2,3-dihydro-2-oxo-6-benzoxazolyl)-3-oxopropyl]-, (3,5-dichlorophenyl)methyl ester;1-Piperazinecarboxylic acid, 4-[3-(2,3-dihydro-2-oxo-6-benzoxazolyl)-3-oxopropyl]-, (3,5-dichlorophenyl)methyl ester;6-(3-(Piperazin-1-yl)propanoyl)-benzo[d]oxazol-2(3H)-one;6-(3-(Piperazin-1-yl)propanoyl)-benzo[d]oxazol-2(3H)-one;6-(3-(Piperazin-1-yl)propanoyl)-benzo[d]oxazol-2(3H)-one;NCGC00346939-01;NCGC00346939-01;NCGC00346939-01;BDBM50187693;BDBM50187693;BDBM50187693;Q27456612;Q27456612;Q27456612;Atx Inhibitor III;Atx Inhibitor III;Atx Inhibitor III;(3,5-dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate;(3,5-dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate;(3,5-dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate;GLXC-03728;GLXC-03728;GLXC-03728;AKOS016011387;AKOS016011387;AKOS016011387;BCP06651;BCP06651;BCP06651;BRD-K50865540-001-01-5;BRD-K50865540-001-01-5;BRD-K50865540-001-01-5;MFCD20527274;MFCD20527274;MFCD20527274;s8218;s8218;s8218;AC-32916;AC-32916;AS-40376;AC-32916;AS-40376;CCG-269523;AS-40376;CCG-269523;6ZO;CCG-269523;6ZO;SCHEMBL3054811;6ZO;GTPL9142;SCHEMBL3054811;SCHEMBL3054811;EX-A137;GTPL9142;GTPL9142;compound 21 [PMID: 26745766];EX-A137;SMR004701264;EX-A137;compound 21 [PMID: 26745766];compound 21 (PMID: 26745766);compound 21 [PMID: 26745766];SMR004701264;PF-8380?;SMR004701264;compound 21 (PMID: 26745766);compound 4 [PMID: 23300119];compound 21 (PMID: 26745766);PF-8380?;MLS006010144;PF-8380?;compound 4 [PMID: 2330...
EINEC:
分子式：C22H21CL2N3O5
分子量：478.3252
搜索质检报告(COA)
搜索MSDS
相关产品

已经到最底了
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
© 2010-2025 郑州阿尔法化工有限公司  版权所有，并保留所有权利 豫ICP备19002673号-1 
技术支持：库价化学(KuuJia)
批量搜索 关闭
批处理可以通过CAS号，CAS号，每行一个搜索
...

4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯苄酯
3,5-Dichlorobenzyl 4-(3-oxo-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)propyl)piperazine-1-carboxylate;PF-8380;3,5-Dichlorobenzyl 4-(3-oxo-3-(2-oxo-2,3-dihydrobenzo-[d]oxazol-6-yl)propyl)piperazine-1-carboxylate;PF 8380;PF-8380, ATX Inhibitor;3,5-dichlorobenzyl 4-[3-oxo-3-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propyl]piperazine-1-carboxylate;AK120450;CS-0591;HY-13344;SureCN3054811;X5984;4-[3-(2,3-Dihydro-2-oxo-6-benzoxazolyl)-3-oxopropyl]-1-piperazinecarboxylic acid (3,5-dichlorophenyl)methyl ester;4-[3-Oxo-3-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propyl]piperazine-1-carboxylic acid 3,5-dichlorobenzyl ester;PF8380;T582DIM5A4;(3,5-Dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate;MLS00601;Atx Inhi;C22H21Cl2N3O5;C22H21Cl2N3O5;C22H21Cl2N3O5;CHEMBL3186509;CHEMBL3186509;CHEMBL3186509;DTXSID50649524;DTXSID50649524;DTXSID50649524;compound 4 (PMID: 23300119);compound 4 (PMID: 23300119);compound 4 (PMID: 23300119);2(3H)-Benzoxazolone, 6-(1-oxo-3-(1-piperazinyl)propyl)-;2(3H)-Benzoxazolone, 6-(1-oxo-3-(1-piperazinyl)propyl)-;2(3H)-Benzoxazolone, 6-(1-oxo-3-(1-piperazinyl)propyl)-;HMS3740G07;HMS3740G07;HMS3740G07;1-Piperazinecarboxylic acid, 4-[3-(2,3-dihydro-2-oxo-6-benzoxazolyl)-3-oxopropyl]-, (3,5-dichlorophenyl)methyl ester;1-Piperazinecarboxylic acid, 4-[3-(2,3-dihydro-2-oxo-6-benzoxazolyl)-3-oxopropyl]-, (3,5-dichlorophenyl)methyl ester;1-Piperazinecarboxylic acid, 4-[3-(2,3-dihydro-2-oxo-6-benzoxazolyl)-3-oxopropyl]-, (3,5-dichlorophenyl)methyl ester;6-(3-(Piperazin-1-yl)propanoyl)-benzo[d]oxazol-2(3H)-one;6-(3-(Piperazin-1-yl)propanoyl)-benzo[d]oxazol-2(3H)-one;6-(3-(Piperazin-1-yl)propanoyl)-benzo[d]oxazol-2(3H)-one;NCGC00346939-01;NCGC00346939-01;NCGC00346939-01;BDBM50187693;BDBM50187693;BDBM50187693;Q27456612;Q27456612;Q27456612;Atx Inhibitor III;Atx Inhibitor III;Atx Inhibitor III;(3,5-dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate;(3,5-dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate;(3,5-dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate;GLXC-03728;GLXC-03728;GLXC-03728;AKOS016011387;AKOS016011387;AKOS016011387;BCP06651;BCP06651;BCP06651;BRD-K50865540-001-01-5;BRD-K50865540-001-01-5;BRD-K50865540-001-01-5;MFCD20527274;MFCD20527274;MFCD20527274;s8218;s8218;s8218;AC-32916;AC-32916;AS-40376;AC-32916;AS-40376;CCG-269523;AS-40376;CCG-269523;6ZO;CCG-269523;6ZO;SCHEMBL3054811;6ZO;GTPL9142;SCHEMBL3054811;SCHEMBL3054811;EX-A137;GTPL9142;GTPL9142;compound 21 [PMID: 26745766];EX-A137;SMR004701264;EX-A137;compound 21 [PMID: 26745766];compound 21 (PMID: 26745766);compound 21 [PMID: 26745766];SMR004701264;PF-8380?;SMR004701264;compound 21 (PMID: 26745766);compound 4 [PMID: 23300119];compound 21 (PMID: 26745766);PF-8380?;MLS006010144;PF-8380?;compound 4 [PMID: 2330...